Related references
Note: Only part of the references are listed.Quality of Care for Patients With Systemic Lupus Erythematosus: Data From the American College of Rheumatology RISE Registry
Gabriela Schmajuk et al.
ARTHRITIS CARE & RESEARCH (2022)
Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study
Candace H. Feldman et al.
ARTHRITIS CARE & RESEARCH (2021)
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus
Shilpa Arora et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
Delphi procedure in core outcome set development: rating scale and consensus criteria determined outcome selection
Dorien De Meyer et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology
Daniel Xibille-Friedmann et al.
REUMATOLOGIA CLINICA (2019)
Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study
Hung-Lin Chen et al.
JOURNAL OF RHEUMATOLOGY (2018)
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease
M. Iudici et al.
LUPUS (2018)
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
Caroline Gordon et al.
RHEUMATOLOGY (2018)
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
Bernardo A. Pons-Estel et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus
Stephanie O. Keeling et al.
JOURNAL OF RHEUMATOLOGY (2018)
Hydroxychloroquine retinopathy - implications of research advances for rheumatology care
April Jorge et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Lupus nephritis is associated with more corticosteroid-associated organ damage but less corticosteroid non-associated organ damage
Y. B. Joo et al.
LUPUS (2017)
Quality of Care for Systemic Lupus Erythematosus: Mind the Knowledge Gap
Vera Golder et al.
JOURNAL OF RHEUMATOLOGY (2017)
From Childhood to Adulthood: The Trajectory of Damage in Patients With Juvenile-Onset Systemic Lupus Erythematosus
Lily S. H. Lim et al.
ARTHRITIS CARE & RESEARCH (2017)
Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis
Chi Chiu Mok et al.
ARTHRITIS CARE & RESEARCH (2016)
Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis
Ioana Ruiz-Arruza et al.
AUTOIMMUNITY REVIEWS (2015)
Predictors of Long-Term Renal Outcome in Lupus Nephritis Trials Lessons Learned from the Euro-Lupus Nephritis Cohort
Maria Dall'Era et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Ian N. Bruce et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial
Farah Tamirou et al.
LUPUS SCIENCE & MEDICINE (2015)
Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus - the Hopkins Lupus Cohort
Sarah Al Sawah et al.
LUPUS SCIENCE & MEDICINE (2015)
Identification of patients with systemic lupus erythematosus in administrative healthcare databases
J. G. Hanly et al.
LUPUS (2014)
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles et al.
JAMA OPHTHALMOLOGY (2014)
The Systemic Lupus International Collaborating Clinics (SLICC) damage index: A systematic literature review
Emily J. Sutton et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
New insights into mechanisms of therapeutic effects of antimalarial agents in SLE
Daniel J. Wallace et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort
Guillermo J. Pons-Estel et al.
RHEUMATOLOGY (2012)
American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Bevra H. Hahn et al.
ARTHRITIS CARE & RESEARCH (2012)
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Protective Effect of Antimalarial Drugs on Thrombovascular Events in Systemic Lupus Erythematosus
Hyejung Jung et al.
ARTHRITIS AND RHEUMATISM (2010)
Identification and validation of lupus nephritis cases using administrative data
L. B. Chibnik et al.
LUPUS (2010)
Prednisone, Lupus Activity, and Permanent Organ Damage
Mae Thamer et al.
JOURNAL OF RHEUMATOLOGY (2009)
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
Nathalie Costedoat-Chalumeau et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
G. Ruiz-Irastorza et al.
LUPUS (2006)
Systemic lupus erythematosus in three ethnic groups -: XVI.: Association of hydroxychloroquine use with reduced risk of damage accrual
BJ Fessler et al.
ARTHRITIS AND RHEUMATISM (2005)
Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort
Y Molad et al.
LUPUS (2002)
Share Paper
